Skip to main content
Clinical Trials/NCT05525416
NCT05525416
Completed
Not Applicable

Sex Differences in Sympathetic Vascular Reactivity at High Altitude

University of Alberta2 sites in 1 country17 target enrollmentJuly 28, 2022

Overview

Phase
Not Applicable
Intervention
Rhythmic Handgrip
Conditions
Vasodilation
Sponsor
University of Alberta
Enrollment
17
Locations
2
Primary Endpoint
Change in systolic, diastolic, and mean arterial blood pressure
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study aims to investigate sex differences in blood pressure control associated with exposure to acute hypoxia (low oxygen), and short term acclimatization to hypoxia at high altitude.

Detailed Description

About 200 million people worldwide live at high altitudes and millions of others travel to high altitude every year for work or pleasure. At high altitude participants are exposed to a lower than normal level of oxygen, also known as hypoxia. This causes stress to the human body, which will adapt in order to maintain adequate oxygen delivery to its tissues. One of these adaptations is an increase in activity of participants' sympathetic nervous system ("fight or flight" response). Sympathetic nerve activity affects the size of participants' blood vessels, which in turn will affect blood pressure. Men and women regulate their blood pressure in different ways; for example, women tend to have lower blood pressure and sympathetic nerve activity than men. Women also appear to have less constriction of their blood vessels in response to stress. This may be in part because estrogen causes blood vessels to dilate. It may also be due to differences in the receptors which are activated by the sympathetic nervous system. These receptors are called alpha and beta receptors and respond to sympathetic nerve activity in opposite directions. Women represent 50% of the population living at and travelling to high altitude, therefore, it is important to understand the differences in how men and women respond to low oxygen. The main purpose of this study is to examine the differences between men and women in the sympathetic nervous system control of blood vessels during exposure to low oxygen. To study this question, the investigators will test how blood vessels respond to stressors in both men and women. Participants will be recruited at the Canadian sites, and the investigators will test them while they breathe low oxygen for a short amount of time at low altitude. The investigators will also perform assessments on the same participants during a two week stay at high altitude at White Mountain, CA, which is at an altitude of 3,800m. These data will have implications in the basic understanding of differences between male and female physiology. Specifically, to males and females living or travelling to high altitude.

Registry
clinicaltrials.gov
Start Date
July 28, 2022
End Date
February 5, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Between ages of 18-50
  • No medical history of cardiovascular, respiratory, nervous system, or metabolic disease
  • Females must be pre-menopausal

Exclusion Criteria

  • Any known cardiovascular, respiratory, nervous system, or metabolic disease (however, participants with controlled arterial hypertension will not be excluded)
  • Having travelled above 2,000m within 1 month of testing at low and high altitude
  • Females who are pregnant, confirmed by a pregnancy test
  • Females who are post-menopausal
  • Participants that are classified as obese (body mass index \> 30kg⋅m²)
  • Participants who are current daily smokers
  • Those with a known allergy to sulfites
  • Participants taking monoamine oxidase (MAO) inhibitors or tricyclic antidepressants or other medications that have contraindications with the study drugs
  • Participants who are still within the washout period from participating in other studies involving drugs.

Arms & Interventions

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Rhythmic Handgrip

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Sodium Nitroprusside

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Phenylephrine Hydrochloride

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Norepinephrine

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Isometric Handgrip and Post-Exercise Circulatory Occlusion

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Cold Pressor Test

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Propranolol Hydrochloride

Low Altitude

Participants will be assessed at an altitude of \<1050m.

Intervention: Phentolamine Mesylate

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Sodium Nitroprusside

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Phenylephrine Hydrochloride

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Norepinephrine

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Isometric Handgrip and Post-Exercise Circulatory Occlusion

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Rhythmic Handgrip

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Cold Pressor Test

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Propranolol Hydrochloride

High Altitude

Participants will be assessed on a high-altitude expedition at an elevation of 3,800m.

Intervention: Phentolamine Mesylate

Outcomes

Primary Outcomes

Change in systolic, diastolic, and mean arterial blood pressure

Time Frame: 3 minutes

modified oxford

Propranolol

Time Frame: 2 hours

changes in vascular conductance

Change in arterial blood flow

Time Frame: 1 hour 30 minutes

phenylephrine and norepinephrine sensitivity

Cold pressor test

Time Frame: 3 minutes

sympathetic reactivity

Change in vascular conductance

Time Frame: 20 minutes

exercise and metaboreflex reactivity

Phentolamine

Time Frame: 1 hour

changes in vascular conductance

Study Sites (2)

Loading locations...

Similar Trials